Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

250
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
250
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

6.1K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
6.1K
Overview of Carbohydrate Metabolism01:19

Overview of Carbohydrate Metabolism

3.9K
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
3.9K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

3.9K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.9K
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

14.6K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
14.6K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

5.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Testosterone Reference Ranges in Women, Adolescent Girls, and Children: The 2024 PCOS Challenge-CDC Stakeholder Meeting.

The Journal of clinical endocrinology and metabolism·2026
Same author

Dynamic modulation of LH secretion by continuous kisspeptin infusion in healthy men.

Hormones (Athens, Greece)·2026
Same author

Insulin resistance: current methods of predicting and need for improved models.

Pediatric research·2026
Same author

Saving the Eye, Counting the Cost: Rethinking Treatment Burden in Unilateral Retinoblastoma.

Clinical & experimental ophthalmology·2026
Same author

Adipose Depot Changes and Associated Metabolic Risk in the Longitudinal Health Influences of Puberty Study.

Pediatric obesity·2026
Same author

Disparities in Medication Treatment of Type 2 Diabetes and Obesity.

Pediatrics·2026

Related Experiment Video

Updated: Feb 28, 2026

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model
09:44

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model

Published on: March 5, 2022

3.4K

Metabolic Implications of PCOS.

Amna Naveed1, Rachana Shah2, Angelina Bernier3

  • 1Division of Pediatric Endocrinology, Department of Pediatrics, Massachusetts General Hospital for Children, Boston, MA 02114, USA.

Current Pediatrics Reports
|February 26, 2026
PubMed
Summary

Adolescents with Polycystic Ovary Syndrome (PCOS) face increased risks of metabolic diseases like insulin resistance and hepatic steatosis. Early diagnosis and lifestyle changes are crucial to prevent long-term health issues.

Keywords:
AdiposityAdolescentsCardiometabolic RiskHepatic SteatosisInsulin ResistancePolycystic Ovary Syndrome

More Related Videos

Author Spotlight: Investigating the Mechanisms and Inducing Models of Polycystic Ovary Syndrome
04:49

Author Spotlight: Investigating the Mechanisms and Inducing Models of Polycystic Ovary Syndrome

Published on: July 5, 2024

1.9K
A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome
08:20

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome

Published on: October 2, 2018

12.0K

Related Experiment Videos

Last Updated: Feb 28, 2026

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model
09:44

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model

Published on: March 5, 2022

3.4K
Author Spotlight: Investigating the Mechanisms and Inducing Models of Polycystic Ovary Syndrome
04:49

Author Spotlight: Investigating the Mechanisms and Inducing Models of Polycystic Ovary Syndrome

Published on: July 5, 2024

1.9K
A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome
08:20

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome

Published on: October 2, 2018

12.0K

Area of Science:

  • Endocrinology
  • Pediatric Endocrinology
  • Metabolic Health

Background:

  • Polycystic Ovary Syndrome (PCOS) is a prevalent endocrine disorder in women.
  • Adolescents with PCOS exhibit heightened risks for cardiometabolic comorbidities.
  • Challenges exist in diagnosing PCOS and cardiometabolic disease in adolescence.

Purpose of the Study:

  • To review metabolic disease risks in adolescents with PCOS.
  • To examine the association between PCOS phenotypes and metabolic risk.
  • To understand the progression of metabolic risk into adulthood.

Main Methods:

  • Literature review of studies on PCOS in adolescents.
  • Analysis of metabolic risk factors including insulin resistance, cardiovascular and adipose tissue dysfunction, and hepatic steatosis.
  • Exploration of disease phenotypes and their link to metabolic outcomes.

Main Results:

  • Adolescents with PCOS demonstrate increased susceptibility to insulin resistance.
  • Cardiovascular and adipose tissue dysfunction are prevalent in this group.
  • Hepatic steatosis is a significant concern for adolescents with PCOS.

Conclusions:

  • Timely diagnosis of PCOS in adolescents is critical.
  • Targeted lifestyle interventions can mitigate cardiometabolic risk.
  • Early management can alter the long-term health trajectory for adolescents with PCOS.